These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35195579)

  • 1. Mesonephric-like Endometrial Carcinoma: Results From Immunohistochemical Screening of 300 Endometrial Carcinomas and Carcinosarcomas for This Often Overlooked and Potentially Aggressive Entity.
    Mills AM; Jenkins TM; Howitt BE; Fan J; Ring KL; Cook I
    Am J Surg Pathol; 2022 Jul; 46(7):921-932. PubMed ID: 35195579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Combined Morphologic and Molecular Approach to Retrospectively Identify KRAS-Mutated Mesonephric-like Adenocarcinomas of the Endometrium.
    Kolin DL; Costigan DC; Dong F; Nucci MR; Howitt BE
    Am J Surg Pathol; 2019 Mar; 43(3):389-398. PubMed ID: 30489318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
    Espinosa I; D'Angelo E; Corominas M; Gonzalez A; Prat J
    Hum Pathol; 2018 Jan; 71():65-73. PubMed ID: 29079180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premature Classification of Early-stage Endometrioid Ovarian Carcinoma With Mesonephric-like Differentiation as Mesonephric-like Adenocarcinoma.
    Miyama Y; Ogasawara A; Hasegawa K; Yasuda M
    Int J Gynecol Pathol; 2024 Jul; 43(4):362-372. PubMed ID: 38870078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen/Progesterone Receptor Loss, CTNNB1 and KRAS Mutations Are Associated With Local Recurrence or Distant Metastasis in Low-Grade Endometrial Endometrioid Carcinoma.
    Chibbar R; Foerstner S; Suresh J; Chibbar R; Piche A; Kundapur D; Kanthan R; Kundapur V; Lee CH; Agrawal A; Lai R
    Appl Immunohistochem Mol Morphol; 2023 Mar; 31(3):181-188. PubMed ID: 36695555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract.
    Pors J; Cheng A; Leo JM; Kinloch MA; Gilks B; Hoang L
    Am J Surg Pathol; 2018 Dec; 42(12):1596-1606. PubMed ID: 30148742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial Carcinosarcomas are Almost Exclusively of p53abn Molecular Subtype After Exclusion of Mimics.
    Huvila J; Jamieson A; Pors J; Hoang L; Mirkovic J; Cochrane D; McAlpine JN; Gilks CB
    Int J Gynecol Pathol; 2024 Sep; 43(5):506-514. PubMed ID: 38303106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesonephric-like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric-like carcinosarcomas.
    Mirkovic J; Olkhov-Mitsel E; Amemiya Y; Al-Hussaini M; Nofech-Mozes S; Djordjevic B; Kupets R; Seth A; McCluggage WG
    Histopathology; 2023 Jun; 82(7):978-990. PubMed ID: 36860193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesonephric-like Carcinoma of the Endometrium: A Subset of Endometrial Carcinoma With an Aggressive Behavior.
    Euscher ED; Bassett R; Duose DY; Lan C; Wistuba I; Ramondetta L; Ramalingam P; Malpica A
    Am J Surg Pathol; 2020 Apr; 44(4):429-443. PubMed ID: 31725471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma.
    Horn LC; Höhn AK; Krücken I; Stiller M; Obeck U; Brambs CE
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):971-983. PubMed ID: 31927619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study.
    Espinosa I; De Leo A; D'Angelo E; Rosa-Rosa JM; Corominas M; Gonzalez A; Palacios J; Prat J
    Hum Pathol; 2018 Feb; 72():100-106. PubMed ID: 29133142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.
    Murali R; Davidson B; Fadare O; Carlson JA; Crum CP; Gilks CB; Irving JA; Malpica A; Matias-Guiu X; McCluggage WG; Mittal K; Oliva E; Parkash V; Rutgers JKL; Staats PN; Stewart CJR; Tornos C; Soslow RA
    Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S40-S63. PubMed ID: 30550483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial Adenocarcinomas With Significant Mucinous Differentiation: A Characterization of Intratumoral Heterogeneity of KRAS Mutations in Mucinous and Endometrioid Histologic Components.
    Jackson CL; Hang S; Hansen K; He M; Sung CJ; Quddus MR; Xiong M; Wang Y; Patel NR; Lawrence WD; Xiong J
    Int J Gynecol Cancer; 2018 Feb; 28(2):241-247. PubMed ID: 29303928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Immunohistochemical Analysis of Mesonephric Marker Expression in Low-grade Endometrial Endometrioid Carcinoma.
    Lee Y; Choi S; Kim HS
    Int J Gynecol Pathol; 2024 May; 43(3):221-232. PubMed ID: 37566876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen Receptor Immunohistochemical Expression in Undifferentiated/Dedifferentiated Endometrial Carcinoma.
    Cao J; Hacking S; Chavarria-Bernal HD; Bhuiya TA; Khutti S
    Int J Gynecol Pathol; 2022 Jan; 41(1):28-34. PubMed ID: 33399351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract.
    Mirkovic J; McFarland M; Garcia E; Sholl LM; Lindeman N; MacConaill L; Dong F; Hirsch M; Nucci MR; Quick CM; Crum CP; McCluggage WG; Howitt BE
    Am J Surg Pathol; 2018 Feb; 42(2):227-233. PubMed ID: 28984674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FIGO Grade 3 Endometrioid Adenocarcinomas With Diffusely Aberrant β-Catenin Expression: An Aggressive Subset Resembling Cutaneous Pilomatrix Carcinomas.
    Weisman P; Park KJ; Xu J
    Int J Gynecol Pathol; 2022 Mar; 41(2):126-131. PubMed ID: 33811207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of oestrogen receptor expression in endometrial carcinomas of no specific molecular profile.
    Alafraidi M; Hoang L; Howitt BE; Longacre TA; McAlpine JN; Jamieson A; Singh N; Gilks CB; Pors J
    Histopathology; 2024 Oct; 85(4):660-670. PubMed ID: 38890776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases.
    Darvishian F; Hummer AJ; Thaler HT; Bhargava R; Linkov I; Asher M; Soslow RA
    Am J Surg Pathol; 2004 Dec; 28(12):1568-78. PubMed ID: 15577675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.